Janux Therapeutics (JANX) Operating Margin (QoQ) (2021 - 2024)

Janux Therapeutics (JANX) Operating Margin (QoQ) (2021 - 2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Janux Therapeutics 985.11 Mn 985.11 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2024 -800,911.00
Jun 30, 2024 145,495.00
Mar 31, 2024 -95,459.00
Dec 31, 2023 -2,746.00
Sep 30, 2023 133,467.00
Jun 30, 2023 -97,263.00
Mar 31, 2023 -34,824.00
Dec 31, 2022 35,200.00
Sep 30, 2022 -26,419.00
Jun 30, 2022 12,238.00
Mar 31, 2022 -1,746.00
Dec 31, 2021 10,595.00
Sep 30, 2021 35,637.00
Jun 30, 2021 -69,604.00